Search Results - "Dushko Dukovski"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Extranodal Diffuse Large B-Cell Lymphoma of the Small Bowel in Female Patient Causing Intestinal Obstruction: A Case Report by Nikolovski, Andrej, Trajkova, Sanja, Dukovski, Dushko, Spirov, Goran, Petrushevska, Gordana

    Published in Lietuvos chirurgija (30-12-2022)
    “…Diffuse large B cell lymphoma is the most common extranodal non-Hodgkin lymphoma of the small intestine accounting for more than 50% of cases. Forty percent of…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    ABCL-337: High-Dose Chemotherapy Regimens in Therapy of NHL DLBCL: A Single-Center Experience by Dukovski, Dushko, Stojanovska, Simona, Ridova, Nevenka, Chadievski, Lazar, Trajkova, Sanja, Panovska-Stavridis, Irina

    Published in Clinical lymphoma, myeloma and leukemia (01-09-2021)
    “…Relapsed-Refractory Diffuse Large B Cell Lymphoma (RR DLBCL), which accounts for approximately one-third of patients with DLBCL, remains a major cause of…”
    Get full text
    Journal Article
  7. 7

    CLL-224 Coronavirus Disease Mortality and Outcome in Macedonian Patients With Chronic Lymphocytic Leukemia: Single-Center Experience by Trajkova, Sanja, Veljanovska, Aleksandra Pivkova, Labacevska, Marija Popova, Ridova, Nevenka, Stojanovska, Simona, Dukovski, Dushko, Stavridis, Irina Panovska

    Published in Clinical lymphoma, myeloma and leukemia (01-10-2022)
    “…Context: Patients with chronic lymphocytic leukemia (CLL) may be more predisposed to coronavirus disease 2019 (COVID-19) due to age, the nature of the disease,…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    CML-104: Efficacy of Generic Imatinib After Switching from Original in Treatment of Patients with Chronic Myeloid Leukemia in the Republic of North Macedonia - A Single-Center Experience by Dukovski, Dushko, Trajkova, Sanja, Stojanovska, Simona, Ridova, Nevenka, Panovska-Stavridis, Irina

    Published in Clinical lymphoma, myeloma and leukemia (01-09-2020)
    “…Imatinib, selective tyrosine kinase inhibitor (TKI), revolutionized treatment of chronic myeloid leukemia (CML) and changed the natural history of the disease…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17